Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
II-Alpha Premium
Latest Articles
Premium
Valiant Surges in January
Stephen Taub
February 22, 2024
Premium
Life Sciences Hedge Funds May Have Moved Past One of Their Worst Stretches
Stephen Taub
February 21, 2024
Premium
Why Tiger Cub Discovery Is Bullish
Stephen Taub
February 13, 2024
Premium
Biopharma’s Boom and Bust
Stephen Taub
February 12, 2024
Premium
The Value Hedge Fund Headed by David Einhorn Starts the Year off Strong
Stephen Taub
February 1, 2024
Premium
Bucking the Trend, Top Hedge Fund Makes Plans for a Second SPAC
Stephen Taub
January 25, 2024
Premium
Macro Funds End 2023 With Mediocre Results
Stephen Taub
January 22, 2024
Premium
How a Hedge Fund Headed by a Former SAC Tech Investor Stands Apart From TMT Rivals
Stephen Taub
January 18, 2024
Premium
A Volatile Hedge Fund Turned It Around Last Year
Stephen Taub
January 17, 2024
Premium
Tiger Funds Play the Long Game
Stephen Taub
January 16, 2024
Premium
Life Sciences Hedge Funds Make a Stunning Recovery
Stephen Taub
January 11, 2024
Premium
Viking Stands Apart From Other Tiger Cubs
Stephen Taub
January 10, 2024
Premium
Jamie Sterne’s Skye Global Soars Again
Stephen Taub
January 9, 2024
Premium
How Dan Loeb’s Hedge Fund Turned It Around in the Fourth Quarter
Stephen Taub
January 8, 2024
Premium
AQR Tops Multistrategy Funds in 2023
Stephen Taub
January 5, 2024
Premium
Tepper’s Two-Year Feat
Stephen Taub
January 4, 2024
Premium
Hedge Fund Faves Beat the Market in the Fourth Quarter
Stephen Taub
January 3, 2024
Premium
Greenlight Finishes the Year on a Losing Note
Stephen Taub
January 2, 2024
More Articles